“…Integrating the NIR dye with a magnetic nanoparticle (NP)-based MR agent to harvest complementary imaging information is challenging, and several problems need to be addressed due to the presence of different physical phenomena within a single platform. Most of the NIR fluorescent probes often suffer from quenching, which is a serious issue when they are capped onto Fe 3 O 4 magnetic NP surfaces. , Although MRI/NIR-FL multimodal agents have been reported, these probes experience solubility issues and suffer from an inconsistency in sensitivity between the MR and fluorescence constituents. , Weissleder and Josephson’s groups have reported dextran-coated cross-linked iron oxide (CLIO) NPs tethered to numerous dyes (FITC, Cy3.5, Alexa-488, Cy5.5). − The combination of MRI and NIR-FL imaging using CLIO-Cy5.5 has been widely used. , We envisage that NIR fluorescence quenching, bleaching of the dye by nucleophilic attack of biological analytes inside the cell, and the aggregation of dye problems could be mitigated by encapsulating the probe inside a macrocycle to construct mechanically interlocked molecules (MIMs), which are coated on the Fe 3 O 4 NPs. − Rotaxane formation could also inhibit free rotation and vibration of the interlocked dye inside the macrocycle, and hence, nonradiative excited-state relaxation pathways are expected to be less favorable. Moreover, the number of targeted multimodal imaging probes that has been developed in this growing field at trivial biological trouble is limited so far. − Being the powerhouse of cells, mitochondria often control plenty of important cellular functions, and they have become one of the crucial targets within numerous cellular organelles. , However, targeting mitochondria is burdensome because of the double-layer membrane and the exceptionally negative inner mitochondrial membrane (IMM) potential (ΔΨ m −220 mV for cancer cells). , It is also challenging to deliver superparamagnetic Fe 3 O 4 NPs inside a specific cellular organelle due to less target selectivity. , The surface coating of the superparamagnetic ultrasmall Fe 3 O 4 NPs by the targeted rotaxanes may promote biocompatibility and diminish nonspecific accumulation.…”